We are a dynamic group of scientists working at the interface of chemistry, biology, and clinical care to identify new therapeutic targets and develop new therapies against cardiometabolic disease.
Division of Cardiology | Zuckerberg San Francisco General Hospital
Department of Medicine | University of California San Francisco